Supernus Pharma (SUPN) Misses Q1 EPS by 13c, Revenues Beat; Offers FY21 Revenues Outlook
Go back to Supernus Pharma (SUPN) Misses Q1 EPS by 13c, Revenues Beat; Offers FY21 Revenues Outlook| SUPERNUS PHARM (NASDAQ: SUPN) | Delayed: 42.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.00 | 52 Week High | $26.84 | |||
| Open | $42.00 | 52 Week Low | $9.51 | |||
| Day High | $42.00 | P/E | N/A | |||
| Day Low | $42.00 | EPS | $-2.62 | |||
| Volume | 18,166 | |||||
